Living with Progressive Multiple Sclerosis? Take Part in Study to Develop Better Treatment Options
If you’re living with progressive MS, you may be able to join a clinical trial testing a potential new treatment that may slow decline, reduce relapses, and help people stay active for longer. These clinical trials are taking place in Christchurch and Auckland. Clinical trials are the backbone of medical progress, rigorously testing drugs and […]
Online Multiple Sclerosis PSYchological WELLbeing Programme (MS PSY-WELLP): Randomised Controlled Trial and interviews
Living with MS can be tough – not just physically, but emotionally too. An exciting new study called MS PSY WELL-P, is a peer-led online program designed to explore how a short course can boost psychological well-being for people with MS. The course is free, flexible, and built to support mental health in everyday life. […]
Research Opportunity for Young Adults
Nikki Singh, a PhD candidate in the Faculty of Medical and Health Sciences, is conducting research into the lived experiences of young people with autoimmune diseases. Research summary: Nikki’s research explores how autoimmune diseases impact identity among young adults aged 18 to 30. While often viewed primarily as biological conditions to be managed, autoimmune diseases […]
MS Get a Head Start – Online Research Study
MS Get a Head Start are looking for people living with multiple sclerosis to take part in a 6-week online exercise and education programme, as part of a research study with AUT. The good news is that you can complete the programme in the comfort of your own home, on days and times that suit […]
Study: CFS biomarkers at the time of diagnosis may aid in MS prognosis
Certain biomarkers in the cerebrospinal fluid (CSF) — the fluid surrounding the brain and spinal cord — around the time of a multiple sclerosis (MS) diagnosis may help predict the time to reaching certain disability milestones among people with a relapsing-remitting (RRMS) disease course, according to findings from a recent study. Such markers also were associated with short-term relapse […]
Could a Simple Blood Test Predict MS
In this article published by MS Australia, their research on antibodies shows promise that perhaps a simple blood test could predict MS one day. Using a large US biobank, blood from people with MS was screened before and after MS onset. Approximately 10% of people with MS harboured antibodies that target a specific sequence contained […]
Survey to Understand the Importance of Being Actively Involved in Research
The International Progressive MS Alliance, in collaboration with MS organisations across the world, is conducting a global survey to find out how people affected by MS feel about being involved in research – including being an author of scientific publications. Are you affected by multiple sclerosis (MS)? Do you want people with MS to be credited […]
Life expectancy for people with MS significantly improved
Dr Ruth Leadbetter (NZBRI), Dr Deborah Mason (NZBRI) and co-authors have published a study on multiple sclerosis mortality in New Zealand in the Journal of Neurology, Neurosurgery and Psychiatry. They studied the life expectancy and risk of dying in New Zealanders with MS compared to the general population. Their results show that people with MS […]
MSOC Study – now recruiting
Lifestyle factors are known to affect the progression of multiple sclerosis (MS). The Multiple Sclerosis Online Course (MSOC) has been developed to deliver a widely accessible and user-friendly educational tool regarding modification of lifestyle related risk factors for people with MS. The intervention consists of arms: 1. An MS Online intervention course based delivering evidence-based information regarding […]
Neurology Research Review – Issue 81
Issue 81 of the Neurology Research Review provides a special focus on Multiple Sclerosis. Download Neurology_Research_Review_Issue_81 by Dr. Jennifer Pereira. In this issue, a post hoc analysis of the ASCLEPIOS I and II trials supports the consideration of ofatumumab as a first line therapy in recently diagnosed treatment-naïve pwMS, the SWEDISH RIFUND-MS study provides evidence […]